Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recurrence × Sentinel Lymph Node Biopsy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 44 Uterine Cervical Neoplasms 10 Melanoma 9 Endometrial Neoplasms 9 Mouth Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 5 Carcinoma, Intraductal, Noninfiltrating 4 Vulvar Neoplasms 3 Triple Negative Breast Neoplasms 3 Rectal Neoplasms 3 Uterine Neoplasms 2 Ovarian Neoplasms 2 Neoplasm Micrometastasis 2 Neoplasm Metastasis 2 Lymphatic Metastasis 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Head and Neck Neoplasms 2 Eccrine Porocarcinoma 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Breast Neoplasms, Male 2 Breast Carcinoma In Situ 2 Anus Neoplasms 2 Waldenstrom Macroglobulinemia 1 Sentinel Lymph Node Biopsy (SLNB) 1 Sentinel Lymph Node 1 Sarcoidosis, Pulmonary 1 Sarcoidosis 1 Rhabdomyosarcoma 1 Recurrence 1

Interventions

Cyclophosphamide 153 Dexamethasone 140 Rituximab 84 fludarabine 79 Lenalidomide 72 Cytarabine 70 fludarabine phosphate 63 Bortezomib 63 Gemcitabine 62 venetoclax 54 Etoposide 53 pomalidomide 51 pembrolizumab 51 Paclitaxel 48 Cisplatin 48 Carboplatin 48 Peripheral Blood Stem Cell Transplantation 47 Filgrastim 40 Radiotherapy 39 Busulfan 37 Calcium Dobesilate 36 Methotrexate 34 Melphalan 34 Bevacizumab 33 carfilzomib 32 Cyclosporine 32 Azacitidine 32 Mycophenolic Acid 30 Vincristine 29 Nivolumab 29

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03719547 2025-07-01

RACC

Karolinska Institutet

Phase NA Recruiting

Uterine Cervical Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡